Alzai Health (TSXV:ALZI) Notes Receivable: C$0.00 Mil (As of Jan. 2026)


TSXV:ALZI Alzai Health Corp TSXV:ALZI
9 GF Score
Price C$0.50
! 1 Warning Sign
View Full Analysis

What is Alzai Health Notes Receivable?

Alzai Health TSXV:ALZI 9 Notes Receivable is C$0.00 Mil as of Jan. 2026. GuruFocus rates TSXV:ALZI with a GF Score™ of 9/100. The stock has 1 warning sign investors should review.

Alzai Health's Notes Receivable for the quarter that ended in Jan. 2026 was C$0.00 Mil.

Alzai Health Notes Receivable Historical Data

* Premium members only.

The historical data trend for Alzai Health's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzai Health Notes Receivable Chart

Alzai Health Annual Data
Trend
Notes Receivable

Alzai Health Quarterly Data
Jan25 Apr25 Jul25 Oct25 Jan26
Notes Receivable 0.00 0.00 0.00 0.00 0.00
TSXV:ALZI
9GF Score
Alzai Health Corp TSXV:ALZI
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzai Health Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of C$0.00 Mil mean?
Alzai Health (TSXV:ALZI) has a Notes Receivable of C$0.00 Mil as of Jan. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Alzai Health and its competitors.
Is Alzai Health's Notes Receivable too high?
Alzai Health's current Notes Receivable is C$0.00 Mil. Overall, Alzai Health has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Alzai Health's Notes Receivable compare to VRTX and REGN?
Alzai Health's Notes Receivable of C$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Alzai Health and its competitors. Alzai Health's current Notes Receivable is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzai Health stock overvalued right now?
Alzai Health (TSXV:ALZI) has a current Notes Receivable of C$0.00 Mil. The current Notes Receivable is C$0.00 Mil. Alzai Health's overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Alzai Health (TSXV:ALZI), the current Notes Receivable is C$0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alzai Health Business Description

Address 22 Adelaide Street West, Suite 3400, Toronto, ON, CAN, M5H 4E3
Alzai Health Corp is a healthcare company focused on comprehensive health solutions. It is an AI-driven Alzheimer's disease risk screening platform, enabling disease prevention and early disease diagnosis to improve patient outcomes. The company uses low-cost, non-invasive, pre-existing biomarker data present in nearly all Electronic Medical Records of the relevant age demographic. It aims to address the unmet need in Alzheimer's screening, enabling early detection and mitigation driving to diagnosis, therapy or prevention.
9GF Score

Get the complete analysis for TSXV:ALZI

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.50
Price